Elemental Analysis

Trace element detection, impurity profiling, heavy‑metal contamination analysis, packaging interactions
Pharmaceutical manufacturers face growing pressure to minimize product risk across the entire value chain—from raw material sourcing to final dosage forms. Impurities, cross‑contamination, counterfeit compounds, formulation inconsistencies, and raw material variability all pose significant threats to patient safety, regulatory compliance, and brand integrity. Yet many organizations still rely on incomplete analytical coverage or outdated testing methods, leaving critical blind spots in quality and forensic investigations.
Modern pharma forensics demands:
To meet these demands, pharmaceutical quality, analytical, and forensic teams require robust, complementary analytical technologies that deliver speed, confidence, and reproducibility.
HORIBA’s analytical tools help pharmaceutical organizations move beyond reactive testing toward proactive risk mitigation and forensic readiness—without sacrificing speed or sample integrity.

Do you have any questions or requests? Use this form to contact our specialists.